News
ONCS
--
0.00%
--
OncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the commencement of an investigator-initiated Phase 2 study led by Senior Member and Professor Ahmad A. Tarhini, M.D., Ph.D
PR Newswire · 08/27 13:30
OncoSec Announces Initiation Of Phase 2 Study At The Moffitt Cancer Center To Evaluate Combination Of TAVO Plus OPDIVO As Neoadjuvant Therapy For Melanoma
Study to Assess the Potential of TAVO in Combination with Anti-PD-1 Checkpoint Inhibitors to Improve Overall Outcomes such as Operability, Pathologic Tumor Response and Long-Term Disease Control in Early Melanoma
Benzinga · 08/27 12:36
OncoSec to Present at the LD 500 Virtual Conference on September 2, 2020
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer will present at the LD 500 Virtual Conference on Wednesday
PR Newswire · 08/25 13:30
OncoSec Medical shares are trading lower after the company announced a common stock offering of 4.61 million shares at $3.25 per share.
Benzinga · 08/17 16:49
SRNE, UBX among premarket losers
Unity Biotechnology (UBX) -51% on stumble with lead drug.Interpace Biosciences (IDXG) -19%.Taiwan Liposome (TLC) -16%.ThermoGenesis Holdings (THMO) -14% on Q2 earnings.Midatech Pharma (MTP) -12%.OncoSec Medical (ONCS) -12% after pricing $15M-share offering.Sorrento Therapeutics (SRNE) -11% after Yale's saliva-based Covid-19
Seekingalpha · 08/17 12:11
OncoSec Medical Prices 4.61M Share Offering at $3.25/Share
Benzinga · 08/17 11:19
OncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead
SmarterAnalyst · 08/17 08:18
OncoSec Medical prices $15M-share offering
OncoSec Medical (ONCS) inks agreements for the purchase of an aggregate 4,608,589 shares of the Company at $3.25/share for gross proceeds of ~$15M.Closing date is August 19.Previous close as on
Seekingalpha · 08/17 04:09
OncoSec Medical intends to offer common stock
OncoSec Medical (ONCS) announced Friday it intends to offer common stock in a public offering.OncoSec "intends to use the net proceeds from this offering for clinical, regulatory, manufacturing and, if
Seekingalpha · 08/16 16:20
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec") today announced that it intends to offer and sell shares of its common stock in a public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering
PR Newswire · 08/15 00:42
The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)
Benzinga · 08/12 11:29
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 07/30 12:09
OncoSec promotes Lellie Malloy Foerter as COO
Seeking Alpha · 07/27 13:07
New operating chief at OncoSec
Seeking Alpha · 07/27 13:06
OncoSec Appoints Kellie Malloy Foerter As Chief Operating Officer
Benzinga · 07/27 13:04
OncoSec Appoints Kellie Malloy Foerter as Chief Operating Officer
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced that Kellie Malloy Foerter, previously Chief Clinical Development Officer, has been appointe
PR Newswire · 07/27 13:00
The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)
Benzinga · 07/21 11:59
80 Biggest Movers From Friday
Gainers Berkeley Lights, Inc. (NASDAQ: BLI) shares jumped 197.5% to close at $65.45 on Friday after the company priced its 8.1 million share IPO at $22 per share.
Benzinga · 07/20 09:11
The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)
Benzinga · 07/16 12:31
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)
Benzinga · 07/15 11:30